ACEI和ARB类药物在心房颤动治疗中的应用  

Application of ACEI and ARB drugs in the treatment of atrial fibrillation

作　　者：房越 梁兆光[1] FANG Yue;LIANG Zhao-guang(Department of Cardiology,First Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150001,China)

机构地区：[1]哈尔滨医科大学附属第一医院心内科,黑龙江哈尔滨150001

出　　处：《心血管康复医学杂志》2021年第2期215-219,共5页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘　　要：心房颤动是临床最常见的心律失常之一。有研究表明肾素-血管紧张素系统的激活可能参与心房颤动的发生、维持和发展过程;血管紧张素转换酶抑制剂(ACEI)和血管紧张素Ⅱ受体阻滞剂(ARB)可以在心房颤动的预防和治疗中发挥重要作用,本文对ACEI和ARB类药物在心房颤动治疗中的应用做一综述。Atrial fibrillation(AF)is one of the most frequent arrhythmias in clinic.Studies have shown that activation of renin-angiotensin system may be involved in the occurrence,maintenance and development of AF.Angiotensin-converting enzyme inhibitors(ACEI)and angiotensin II receptor blockers(ARB)may play an important role in the prevention and treatment of AF.Therefore,the present article makes a review on the application of ACEI and ARB drugs in the treatment of AF.

关 键 词：心房颤动 血管紧张素转换酶抑制药 血管紧张素受体拮抗剂 

分 类 号：R541.75[医药卫生—心血管疾病]